Finance

Lists
Why is 300702 up 2.10%?
Dive Deeper
300702:SHE
Zhejiang Tianyu Pharmaceutical Co Ltd
CNÂ¥20.92
+2.10%
(+0.43) 1D
Nov 4, 3:04:43 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300702...
Open
CNÂ¥20.56
High
CNÂ¥21.08
Low
CNÂ¥20.40
Mkt. cap
7.13B
Avg. vol.
3.38M
Volume
2.38M
Dividend
0.24%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 2, 2026
P/E ratio
123.42
52-wk high
CNÂ¥27.80
52-wk low
CNÂ¥17.98
EPS
CNÂ¥0.17
Shares outstanding
347.98M
No. of employees
5K
Open
CNÂ¥20.56
High
CNÂ¥21.08
Low
CNÂ¥20.40
Mkt. cap
7.13B
Avg. vol.
3.38M
Volume
2.38M
Dividend
0.24%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 2, 2026
P/E ratio
123.42
52-wk high
CNÂ¥27.80
52-wk low
CNÂ¥17.98
EPS
CNÂ¥0.17
Shares outstanding
347.98M
No. of employees
5K
News stories
From web sources and news partners
About Zhejiang Tianyu Pharmaceutical Co Ltd
CEO-
Employees4.69K
Founded1993
Headquarters-
SectorPharmaceutical industry
Industry-
Websitetianyupharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
774.15M
811.67M
1.20B
1.01B
Cost of goods sold
604.51M
548.33M
880.22M
643.35M
Cost of revenue
604.51M
548.33M
880.22M
643.35M
Research and development expenses
60.66M
52.90M
71.96M
68.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
207.09M
123.93M
149.32M
175.74M
Operating expense
283.89M
178.76M
242.96M
231.38M
Total operating expenses
888.40M
727.09M
1.12B
874.73M
Operating income
-114.24M
84.58M
75.89M
131.64M
Other non operating income
-8.84M
-12.56M
11.16M
-76.21M
EBT including unusual items
-76.40M
46.43M
72.96M
42.37M
EBT excluding unusual items
-129.49M
63.99M
56.10M
97.00M
Income tax expense
4.82M
4.24M
10.54M
-6.49M
Effective tax rate
-6.31%
9.13%
14.44%
-15.31%
Other operating expenses
12.54M
2.51M
14.52M
-6.44M
Net income
-81.22M
42.19M
61.72M
46.58M
Net profit margin
-10.49%
5.20%
5.15%
4.63%
Earnings per share
-
-
-
-
Interest and investment income
1.50M
1.45M
2.73M
21.04M
Interest expense
-9.63M
-9.48M
-11.57M
-1.58M
Net interest expenses
-8.13M
-8.02M
-8.84M
19.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.39M
171.43M
174.51M
218.50M
Gain or loss from assets sale
434.71K
-
-1.29M
1.29M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps